EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV

Abstract

Authors

V. Vardanega E. New D. Mezzio L.A. Eddowes

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×